130 related articles for article (PubMed ID: 1626064)
1. An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.
Bois FY; Paxman DG
Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):122-36. PubMed ID: 1626064
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism.
Bois FY; Smith MT; Spear RC
Toxicol Lett; 1991 May; 56(3):283-98. PubMed ID: 2035176
[TBL] [Abstract][Full Text] [Related]
3. Benzene toxicokinetics in humans: exposure of bone marrow to metabolites.
Watanabe KH; Bois FY; Daisey JM; Auslander DM; Spear RC
Occup Environ Med; 1994 Jun; 51(6):414-20. PubMed ID: 8044234
[TBL] [Abstract][Full Text] [Related]
4. Effect of exposure concentration, exposure rate, and route of administration on metabolism of benzene by F344 rats and B6C3F1 mice.
Sabourin PJ; Bechtold WE; Griffith WC; Birnbaum LS; Lucier G; Henderson RF
Toxicol Appl Pharmacol; 1989 Jul; 99(3):421-44. PubMed ID: 2749731
[TBL] [Abstract][Full Text] [Related]
5. Analysis of OSHA's short-term-exposure limit for benzene.
Paxman D; Rappaport SM
Regul Toxicol Pharmacol; 1990 Jun; 11(3):275-87. PubMed ID: 2196637
[TBL] [Abstract][Full Text] [Related]
6. Differences in the metabolism and disposition of inhaled [3H]benzene by F344/N rats and B6C3F1 mice.
Sabourin PJ; Bechtold WE; Birnbaum LS; Lucier G; Henderson RF
Toxicol Appl Pharmacol; 1988 Jun; 94(1):128-40. PubMed ID: 3376110
[TBL] [Abstract][Full Text] [Related]
7. In vitro conjugation of benzene metabolites by human liver: potential influence of interindividual variability on benzene toxicity.
Seaton MJ; Schlosser P; Medinsky MA
Carcinogenesis; 1995 Jul; 16(7):1519-27. PubMed ID: 7614685
[TBL] [Abstract][Full Text] [Related]
8. A physiological model for simulation of benzene metabolism by rats and mice.
Medinsky MA; Sabourin PJ; Lucier G; Birnbaum LS; Henderson RF
Toxicol Appl Pharmacol; 1989 Jun; 99(2):193-206. PubMed ID: 2734786
[TBL] [Abstract][Full Text] [Related]
9. Population toxicokinetics of benzene.
Bois FY; Jackson ET; Pekari K; Smith MT
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1405-11. PubMed ID: 9118927
[TBL] [Abstract][Full Text] [Related]
10. A toxikinetic model for simulation of benzene metabolism.
Medinsky MA; Sabourin PJ; Lucier G; Birnbaum LS; Henderson RF
Exp Pathol; 1989; 37(1-4):150-4. PubMed ID: 2637146
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of benzene.
Travis CC; Quillen JL; Arms AD
Toxicol Appl Pharmacol; 1990 Mar; 102(3):400-20. PubMed ID: 2315912
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
Bois FY; Woodruff TJ; Spear RC
Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in benzene disposition in male C57BL/6N mice described by a physiologically based pharmacokinetic model.
McMahon TF; Medinsky MA; Birnbaum LS
Toxicol Lett; 1994 Dec; 74(3):241-53. PubMed ID: 7871548
[TBL] [Abstract][Full Text] [Related]
14. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
Watanabe KH; Bois FY
Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
[TBL] [Abstract][Full Text] [Related]
15. Identification of quinol thioethers in bone marrow of hydroquinone/phenol-treated rats and mice and their potential role in benzene-mediated hematotoxicity.
Bratton SB; Lau SS; Monks TJ
Chem Res Toxicol; 1997 Aug; 10(8):859-65. PubMed ID: 9282834
[TBL] [Abstract][Full Text] [Related]
16. Benzene and phenol metabolism by mouse and rat liver microsomes.
Schlosser PM; Bond JA; Medinsky MA
Carcinogenesis; 1993 Dec; 14(12):2477-86. PubMed ID: 8269615
[TBL] [Abstract][Full Text] [Related]
17. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
Cox LA
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic considerations in benzene physiological model development.
Medinsky MA; Kenyon EM; Seaton MJ; Schlosser PM
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1399-404. PubMed ID: 9118926
[TBL] [Abstract][Full Text] [Related]
19. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.
Spear RC; Bois FY
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):61-6. PubMed ID: 7737043
[TBL] [Abstract][Full Text] [Related]
20. The effect of dose, dose rate, route of administration, and species on tissue and blood levels of benzene metabolites.
Henderson RF; Sabourin PJ; Bechtold WE; Griffith WC; Medinsky MA; Birnbaum LS; Lucier GW
Environ Health Perspect; 1989 Jul; 82():9-17. PubMed ID: 2792053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
